Evidence map›Paper›PMID 33430809›Full record

Observational studyBMC pregnancy and childbirth2021

Apgar score and neonatal mortality in China: an observational study from a national surveillance system.

Yi Mu, Mingrong Li, Jun Zhu, Yanping Wang, Aiyun Xing, Zheng Liu, Yanxia Xie, Xiaodong Wang, Juan Liang

Abstract readObservational Study
In one paragraph

Observational study in BMC pregnancy and childbirth, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Apgar scores correlate with survival rate at discharge in extremely preterm infants with gestational age of 25-27 weeks.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2022
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yi MuNational Office for Maternal and Child Health Surveillance of China, West China Second University Hospital, Sichuan University, Ren Min South Road Section 3 No. 17, Chengdu, Sichuan, China.
Mingrong LiNational Office for Maternal and Child Health Surveillance of China, West China Second University Hospital, Sichuan University, Ren Min South Road Section 3 No. 17, Chengdu, Sichuan, China.
Jun ZhuNational Office for Maternal and Child Health Surveillance of China, West China Second University Hospital, Sichuan University, Ren Min South Road Section 3 No. 17, Chengdu, Sichuan, China.
Yanping WangNational Office for Maternal and Child Health Surveillance of China, West China Second University Hospital, Sichuan University, Ren Min South Road Section 3 No. 17, Chengdu, Sichuan, China.
Aiyun XingDepartment of Obstetrics, West China Second University Hospital, Sichuan University, Ren Min South Road Section 3 No. 17, Chengdu, Sichuan, China.
Zheng LiuNational Office for Maternal and Child Health Surveillance of China, West China Second University Hospital, Sichuan University, Ren Min South Road Section 3 No. 17, Chengdu, Sichuan, China.
Yanxia XieNational Office for Maternal and Child Health Surveillance of China, West China Second University Hospital, Sichuan University, Ren Min South Road Section 3 No. 17, Chengdu, Sichuan, China. xieyanxia@motherchildren.com.ORCID http://orcid.org/0000-0002-0980-8773
Xiaodong WangDepartment of Obstetrics, West China Second University Hospital, Sichuan University, Ren Min South Road Section 3 No. 17, Chengdu, Sichuan, China. drwangxiaodong@126.com.
Juan LiangNational Office for Maternal and Child Health Surveillance of China, West China Second University Hospital, Sichuan University, Ren Min South Road Section 3 No. 17, Chengdu, Sichuan, China.

Funding

China Medical Board 11-065The National Key R&D Program of China 2019YFC1005100UNICEF 2019EJH015World Health Organization CHN-12-MCN-004888
6 · The paper itself

Abstract

backgroundTo examine the association between the Apgar score and neonatal mortality over gestational age in China and to explore whether this association changed when Apgar scores were combined at 1 and 5 min.

methodsData for all singleton live births collected from 438 hospitals between 2012 and 2016 were used in this study. Poisson regression with a robust variance estimator adjusted for a complete set of confounders was used to describe the strength of the association between the Apgar score and neonatal mortality.

resultsThe relative risks of neonatal death-associated intermediate Apgar score at 5 min peaked at 39-40 weeks of gestation and subsequently decreased if the gestational age increased to 42 weeks or above, in contrast to the low Apgar score. Among both preterm and term new-borns with Apgar scores at 5 min, new-borns that were not small for gestational age had a lower mortality rate than those that were small for gestational age. The association between Apgar score and the neonatal mortality was even stronger when scores at 1 and 5 min were combined.

conclusionsApgar score is not only meaningful for preterm new-borns but also useful for term new-borns, especially term new-borns that are not small for gestational age. Once the baby's Apgar score worsens, timely intervention is needed. There is still a gap between China and high-income countries in terms of sustained treatment of new-borns with low Apgar scores.

Indexed as

Apgar ScoreInfant MortalityAdultChinaFemaleGestational AgeHumansInfantInfant, NewbornPopulation SurveillancePregnancyPregnancy OutcomeApgar scoreChinaNeonatal mortalitySmall for gestational age

Identifiers

PMID33430809
PMCPMC7802282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.